Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Phase II trials
The second stage in a series of trials to determine the safety and efficacy of a drug before it reaches the public. At this stage, drugs are evaluated for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. The number of participants in these trials can be between 20 and 300.
See also:
Phase I trials
Phase III trials
Phase IV trials
Clinical trial
Clinical trial enrolment
Pre-clinical trials
Related terms
Disease mongering, Data sheet, Patent, Epidemiology, Arm, Balanced Scorecard, Cost-minimisation analysis (CMA), Effectiveness, “P” Medicine, Prior approval, Association of the British Pharmaceutical Industry (ABPI), Generic medicine, Eligibility criteria, Disease awareness marketing, Informed consent,
Subscribe to our email news alerts
-
Senior Medical Writer
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Italy accelerates the path towards digital therapeutics implementation
- AstraZeneca’s mild combination asthma reliever approved in UK
- Powering Rapid Cognitive Analysis with AI
- AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
- Healthware Group report on depression care in Italy highlights need for digital therapeutics
- Masking the truth
- The speed of science and the pace of comms
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
